New Sunscreen Ingredient Approved After Decades!

The U.S. Food and Drug Administration announced a significant approval on June 9, 2026, permitting bemotrizinol for over-the-counter consumer use. This marks the first new sunscreen ingredient to be allowed for such use in the United States since 1999.

Bemotrizinol is not a new compound globally; it has been utilized by consumers in Europe and Asia for decades. Its introduction to the U.S. market is being welcomed by many who advocate for improved sun protection.

This chemical sunscreen acts as a molecular sponge, absorbing UV photons and releasing the energy as heat. A key advantage of bemotrizinol is its photostability, meaning it degrades less readily in sunlight compared to other chemical sunscreens. This allows for a longer duration of protection, potentially lasting four to eight hours.

Furthermore, bemotrizinol effectively filters both UVA and UVB rays, eliminating the need for it to be combined with other ingredients for broad-spectrum coverage. Its molecular structure also favors residing on the skin's surface rather than being readily absorbed into the bloodstream, addressing some consumer concerns about chemical absorption.

Physicists categorize UV light by wavelength, with UVA and UVB being the primary concerns for sunscreens. While UVB rays cause sunburn, UVA rays penetrate deeper, and both can damage skin DNA and contribute to skin cancer. Dermatologists generally recommend using sunscreens with an SPF of at least 30.